July 10, 2022

By Christine Leonard, Senior Associate Editor

PUBLISHED 10 JULY 2022

Presbyopia: How are the Drops Performing?

There are a number of options in the pipeline. Here’s what to expect in the coming years.

In this world, nothing can be said to be certain, except death and taxes—and presbyopia. This inevitable loss of near accommodation affects more than 120 million individuals in the United States and more than two billion globally. Presbyopia treatments have typically included reading glasses, contact lenses, refractive procedures and presbyopia-correcting implants, but there are several pharmacologic candidates in the pipeline now, as well as an FDA-approved drop.  

The current presbyopia-correcting drops in development either constrict the pupil to improve near vision or reduce lens stiffening to improve accommodation. In this article, we’ll review some of the drops in the pipeline, their mechanisms of action and how they’ve been performing in clinical trials.

Read more.

Print